68Ga-DOTA-Arg-Gly-Asp

Known as: 68Ga-DOTA-RGD, 68Ga-DOTA-arginine-glycine-aspartic acid, 68Ga-DOTA-arginyl-glycyl-aspartic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2012
01219942012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-enhanced magnetic resonance imaging (MRI) to a… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2012
2012
In this study, we investigated the relationship between affinity to somatostatin receptor subtype2 (SSTR(2)) and uptake of… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2008
2008
OBJECTIVE Radiolabeled receptor-specific somatostatin analogs labeled with gamma- or beta-emitting radionuclides are useful for… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Radiolabeled sst 2 and sst 3 antagonists are better candidates for tumor targeting than agonists with comparable binding… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
1999
1999
The purpose of this study was to assess the ability of the new blood pool contrast agent meglumine-carboxymethyldextran… (More)
Is this relevant?
1996
1996
In stenosis of a renal artery, angiotensin-converting enzyme inhibitor (ACEI) can induce a decrease in ipsilateral glomerular… (More)
Is this relevant?
1994
1994
RATIONALE AND OBJECTIVES Although gadolinium chelates are mainly eliminated by the kidney, there is limited information about… (More)
Is this relevant?